Gram Research analysis of a 2026 observational cohort study found that vitamin D levels were not significantly linked to COVID-19 severity or 30-day survival in 95 patients. Older age, high inflammation, and existing health conditions were more strongly associated with serious illness. Researchers say larger studies are needed to confirm these results.
A new observational study, reviewed through Gram Research analysis, looked at whether vitamin D levels in the blood affect how sick people become from COVID-19. Researchers measured vitamin D in 95 patients with confirmed COVID-19 and compared them with 64 healthy people. About 59% of the patients had low vitamin D, defined as blood levels below 20 ng/mL. However, vitamin D levels did not show a significant link to illness severity or survival over 30 days in the basic analyses. Instead, older age, high inflammation in the body, and having other health conditions were more strongly tied to serious illness. The researchers noted that the study was small and may have missed modest effects, so larger studies are needed before drawing firm conclusions.
Key Statistics
A 2026 observational cohort study published in the journal Infection found that vitamin D levels were not significantly linked to COVID-19 severity or 30-day survival among 95 patients.
In that study of 95 patients with COVID-19, about 59% had vitamin D deficiency, defined as blood levels below 20 ng/mL.
The same study found that older age, elevated C-reactive protein, and higher comorbidity burden were associated with severe or critical COVID-19.
The Quick Take
- What they studied: Whether vitamin D levels in the blood are linked to how severe COVID-19 becomes and whether patients survive the first 30 days after diagnosis.
- Who participated: 95 people with lab-confirmed COVID-19 and 64 healthy people used for comparison, enrolled between June 2020 and January 2022. That is 159 people in total.
- Key finding: Vitamin D levels were not significantly linked to how severe COVID-19 was or to survival at 30 days. About 59% of patients had low vitamin D. Age, inflammation, and other health conditions were more strongly tied to serious illness.
- What it means for you: Vitamin D levels alone do not appear to predict how seriously you might be affected by COVID-19. Keeping vitamin D at a healthy level may still matter for bone health, but this study does not show that it protects against severe COVID-19. Talk with a doctor before starting or changing any supplement.
The Research Details
This was an observational cohort study, meaning researchers watched and measured people over time rather than assigning them to receive a treatment. The team measured vitamin D in blood samples from 95 patients with COVID-19 and 64 healthy people. They measured two forms of vitamin D: 25(OH)D, which reflects how much vitamin D the body has stored, and 1,25(OH)2D, the active form the body uses. Vitamin D deficiency was defined as a 25(OH)D level below 20 ng/mL.
The researchers then compared vitamin D levels across groups based on how sick patients became and whether they survived 30 days. They used basic statistical tests, including comparisons of averages and tests of how groups differed. They also tracked survival over time using a method called Kaplan-Meier analysis.
The researchers did not adjust their results for other factors such as age, weight, or existing health problems, because complete information on those factors was not available. This makes it harder to tell whether vitamin D itself was responsible for any difference.
Comparing vitamin D levels between sick and less sick patients, and against healthy people, helps show whether there is any obvious connection. This is useful for generating questions, but an observational design can only show associations, not cause and effect. Because the analyses were not adjusted for other factors, age or other conditions could be hiding or distorting a real link. That is why the authors describe their findings as preliminary.
The study was published in Infection, a peer-reviewed medical journal, which means outside experts reviewed it before publication. The researchers used lab-confirmed COVID-19 cases and measured vitamin D with specific blood tests, which are strengths. However, the groups were small, and some subgroups were too small to detect modest effects. The analyses were unadjusted, so the results should be read as a starting point rather than a final answer. A result of “not significant” also does not prove that vitamin D has no effect, only that this study could not detect one.
What the Results Show
The main question was whether vitamin D levels were linked to COVID-19 severity and survival. In the basic analyses, neither 25(OH)D nor 1,25(OH)2D levels were significantly associated with how severe a patient’s illness was or whether they survived 30 days. In plain terms, patients who were sicker did not consistently have noticeably lower vitamin D levels in a way the statistics could confirm.
Vitamin D deficiency was common in this group. About 59% of patients had 25(OH)D levels below 20 ng/mL. This finding shows that low vitamin D was widespread among these patients, although it did not separate mild cases from severe ones in this study.
By contrast, several other factors stood out. Older age, higher levels of C-reactive protein (a marker of inflammation in the body), and a greater number of existing health conditions were associated with severe or critical COVID-19. These links were stronger than any link seen with vitamin D.
The study suggests that inflammation and existing health conditions may matter more for how COVID-19 progresses than vitamin D status does. This is useful because it points attention toward factors that clinicians already track, such as age, inflammation markers, and comorbidities. The high rate of low vitamin D in the group also shows that deficiency is common, which is a reason to check it in routine care, even if it was not tied to outcomes here.
Earlier research on vitamin D and COVID-19 has produced mixed results. Some observational studies found that lower vitamin D was linked to worse outcomes, while some larger clinical trials found little or no benefit from vitamin D supplements. This study adds to the mixed picture. Its findings are consistent with the idea that vitamin D is not a strong, standalone predictor of COVID-19 severity, but its small size means it cannot settle the question on its own.
The study had several important limits. The number of participants was small, and when the groups were divided into smaller subgroups, there were too few people to reliably detect modest associations. The analyses were unadjusted, which means the researchers could not account for age, other illnesses, or other factors that might influence both vitamin D levels and outcomes. Because it was observational, the study cannot prove cause and effect in either direction. Finally, the patients were enrolled during a specific period from June 2020 to January 2022, and COVID-19 treatment and variants changed over time, so results may not apply to every situation today.
The Bottom Line
Based on this study alone, confidence is low that vitamin D levels predict how severe COVID-19 will be, since the results were not statistically significant and the study was small. Confidence is higher that older age, high inflammation, and existing health conditions are linked to more serious COVID-19, which matches a broad body of research. Do not use this study as a reason to skip standard medical care or vaccines. If you have a known vitamin D deficiency, a doctor can help decide whether treatment is appropriate for your general health.
People who are concerned about COVID-19 risk, healthcare professionals who measure vitamin D, and researchers planning larger studies should pay attention. People with confirmed low vitamin D may want to discuss testing and treatment with their doctor. This study is less relevant to people looking for a way to prevent or treat COVID-19 at home, since it does not show that vitamin D changes outcomes. Anyone with kidney disease, a history of high calcium levels, or who takes medications that interact with vitamin D should check with a doctor before using supplements.
This study does not suggest any near-term health benefit from changing vitamin D levels to lower COVID-19 severity. For general vitamin D goals, blood levels usually take several weeks to a few months to change after starting a supplement, and a doctor often retests after about three months. Any benefits for bone or muscle health would build gradually, not within days.
Frequently Asked Questions
Does vitamin D level affect how severe COVID-19 gets?
A 2026 cohort study of 95 COVID-19 patients found no significant link between vitamin D levels and illness severity in basic analyses. Older age, inflammation, and existing health conditions were more strongly tied to severe disease than vitamin D levels were.
How common is low vitamin D in people with COVID-19?
In a 2026 study of 95 COVID-19 patients published in Infection, about 59% had vitamin D deficiency, defined as blood levels below 20 ng/mL. The study did not find that this deficiency predicted severe illness or 30-day survival.
What factors are linked to severe COVID-19 according to recent research?
A 2026 cohort study reported that older age, elevated C-reactive protein (a marker of inflammation), and a higher number of existing health conditions were associated with severe or critical COVID-19. These factors showed stronger links than vitamin D levels did.
Should I take vitamin D supplements to protect against COVID-19?
This study does not show that vitamin D supplements protect against severe COVID-19. Its sample was small and unadjusted, so it cannot settle the question. Speak with a doctor before starting or changing any supplement, especially if you have kidney or calcium-related conditions.
Want to Apply This Research?
- Log your most recent 25(OH)D blood test result (in ng/mL) with its date, along with your daily vitamin D supplement dose in IU. Also record your age group and any diagnosed health conditions, so you can see the full picture when discussing results with your doctor.
- If your doctor has recommended a vitamin D supplement, set a daily reminder and take it with a meal that contains some fat, which can help absorption. Ask your doctor whether a blood test is right for you, and add the appointment to your app calendar. Do not change your dose without medical guidance.
- Track your vitamin D test results and supplement doses every three months, or as your doctor advises, and review trends over the year. Record any illness, including respiratory infections, along with the date and severity, so patterns can be discussed at your annual checkup. Update your health profile if your age-related risk factors, such as blood pressure or other conditions, change.
This article summarizes a single observational study and is for general information only. It does not provide medical advice, diagnosis, or treatment. The study found no significant link between vitamin D and COVID-19 outcomes, but its small size and unadjusted analyses limit what can be concluded. Talk with a qualified healthcare provider before making changes to vitamin D intake, supplements, or COVID-19 care, especially if you have existing health conditions or take medications.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.